Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3317 Clozapine N-oxide (CNO)1 CitationTarget: DREADD LigandsSummary: Metabolite of clozapine, used in chemogenetics.
-
A3330 CP-809101Summary: 5-HT2C receptor agonist
-
A3331 CP-809101 hydrochlorideSummary: 5-HT2C receptor agonist, potent and selective
-
A3443 GranisetronSummary: Serotonin 5-HT3 receptor antagonist
-
A3561 Lu AE58054 HydrochlorideSummary: 5-HT(6)R antagonist
-
A3569 LY 344864Summary: 5-HT1F receptor agonist,potent and selective
-
A3697 PalonosetronSummary: 5-HT3 antagonist
-
A3776 RotigotineSummary: Agonist of dopamine D2/D3 receptor
-
A3777 Rotigotine hydrochlorideSummary: Agonist of dopamine D2/D3 receptor
-
A3778 RS 127445Summary: 5-HT2B receptor antagonist,high affinity